Drug · DIN 02525682 · Veterinary
CREDELIO PLUS
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since August 4, 2022; first marketed August 4, 2022.
- Drug Identification Number (DIN)
- 02525682
- Company (DIN owner)
- Elanco Canada LimitedGuelph, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet (Chewable)
- Route
- Oral
- Class
- Veterinary
- Record last updated
- April 10, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| MILBEMYCIN OXIME | 4.22 MG | |
| LOTILANER | 112.5 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- April 9, 2026: NOC 37280Supplement to a New Drug Submission (SNDS) · Additional Indication (treatment of sarcoptic mange caused by Sarcoptes scabiei)
- December 24, 2025: NOC 36625Supplement to a New Drug Submission (SNDS) · Additional claim for treatment of demodicosis in dogs
- March 4, 2022: NOC 27711New Drug Submission (NDS)
Other DINs named CREDELIO PLUS
- DIN 02525674 · Marketed
- DIN 02525690 · Marketed
- DIN 02525704 · Marketed
- DIN 02525712 · Marketed